EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Increased interval between seizure clusters across time in pediatric patients treated with the immediate‐use seizure medication diazepam nasal spray

James W Wheless iD, Eric Segal iD, Jurriaan M Peters iD, Steven M Wolf iD, Genei Bougher, Charles Davis, Leock Y Ngo iD, Enrique Carrazana iD, Adrian L Rabinowicz iD

Epilepsia · 2026-07 · 67 (7) · 3471-3478

DOI: 10.1002/epi.70256 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Epilepsia, online erschienen am 07.05.2026. Verfasst von James W Wheless und 8 weiteren Autor:innen. Beteiligte Einrichtung: Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Diazepam, Seizures. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Neurelis, Inc., Neurelis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Seizure clusters, intermittent increases in seizure activity that differ from a patient's usual seizure pattern, may occur despite treatment with a daily anti‐seizure medication. Benzodiazepine‐containing immediate‐use seizure medications (ISMs; also called rescue therapies) are the cornerstone of treatment for seizure clusters. Diazepam nasal spray is approved by the U.S. Food and Drug Administration to treat seizure clusters in patients with epilepsy ≥2 years of age. A prior long‐term safety study of diazepam nasal spray showed an increased inter‐seizure cluster interval (SEIzure interVAL [SEIVAL]) in days across a year in patients 6 to 65 years of age. The current analysis focused on changes in SEIVAL over time in a separate study in children with epilepsy 2 to 5 years of age.

Methods

Patients with epilepsy 2 to 5 years of age were enrolled in an open‐label, Phase 1/2a trial of diazepam nasal spray that included a single‐dose pharmacokinetics period, 180‐day safety period, and optional extension period. Doses of 5, 10, or 15 mg were administered based on weight (0.5 mg/kg). A post hoc analysis evaluated SEIVAL for consecutive 90‐day periods overall and in a consistent cohort of patients with persistent use and SEIVALs in each period.

Results

Among enrolled patients ( n = 36), 22 (61.1%) had ≥1 SEIVAL, with a total of 315 SEIVALs recorded. Mean SEIVAL (±SD) doubled from 25.2 (±21.3) days in Period 1 ( n = 20) to 51.9 (±72.4) days in Period 3 ( n = 8). In the consistent cohort ( n = 7), mean SEIVAL increased from 22.1 (±12.7) days in Period 1 to 27.7 (±25.4) days in Period 3. Significance These results corroborate those of the earlier post hoc analysis of data from patients 6 to 65 years of age who received diazepam nasal spray for seizure clusters. These findings suggest a beneficial long‐term treatment effect of diazepam nasal spray beyond acute use as an ISM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDiazepamSeizuresAdolescentChildChild, PreschoolFemaleHumansMaleAdministration, IntranasalNasal SpraysTime Factors

Stichwörter der Autor:innen

acute repetitive seizuresbenzodiazepineintranasalrescue

Substanzen

AnticonvulsantsDiazepamNasal Sprays

Autor:innen und Institutionen

  • Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Hackensack University Medical Center and Northeast Regional Epilepsy Group and Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA.
  • Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatric Neurology, Boston Children's Health Physicians, New York, USA.
  • Department of Neurology, Westchester Medical Center, New York, USA.
  • Northwest Florida Clinical Research Group, Gulf Breeze, Florida, USA.

ORCID-Profile: James W Wheless, Eric Segal, Jurriaan M Peters, Steven M Wolf, Leock Y Ngo, Enrique Carrazana, Adrian L Rabinowicz

Förderung

  • Neurelis, Inc.
  • Neurelis

Zitieren

APA

Wheless, J. W., Segal, E., Peters, J. M., Wolf, S. M., Bougher, G., Davis, C., Ngo, L. Y., Carrazana, E., & Rabinowicz, A. L. (2026). Increased interval between seizure clusters across time in pediatric patients treated with the immediate‐use seizure medication diazepam nasal spray. Epilepsia, 67(7), 3471-3478. https://doi.org/10.1002/epi.70256

Vancouver

Wheless JW, Segal E, Peters JM, Wolf SM, Bougher G, Davis C, et al. Increased interval between seizure clusters across time in pediatric patients treated with the immediate‐use seizure medication diazepam nasal spray. Epilepsia. 2026;67(7):3471-3478. doi:10.1002/epi.70256

BibTeX
@article{Wheless2026,
  author = {Wheless, James W and Segal, Eric and Peters, Jurriaan M and Wolf, Steven M and Bougher, Genei and Davis, Charles and Ngo, Leock Y and Carrazana, Enrique and Rabinowicz, Adrian L},
  title = {Increased interval between seizure clusters across time in pediatric patients treated with the immediate‐use seizure medication diazepam nasal spray},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {7},
  pages = {3471--3478},
  doi = {10.1002/epi.70256}
}
Kostenlos starten →